Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19
- PMID: 34353886
- PMCID: PMC8343166
- DOI: 10.26508/lsa.202000954
Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19
Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by the new coronavirus (SARS-CoV-2) is currently responsible for more than 3 million deaths in 219 countries across the world and with more than 140 million cases. The absence of FDA-approved drugs against SARS-CoV-2 has highlighted an urgent need to design new drugs. We developed an integrated model of the human cell and SARS-CoV-2 to provide insight into the virus' pathogenic mechanism and support current therapeutic strategies. We show the biochemical reactions required for the growth and general maintenance of the human cell, first, in its healthy state. We then demonstrate how the entry of SARS-CoV-2 into the human cell causes biochemical and structural changes, leading to a change of cell functions or cell death. A new computational method that predicts 20 unique reactions as drug targets from our models and provides a platform for future studies on viral entry inhibition, immune regulation, and drug optimisation strategies. The model is available in BioModels (https://www.ebi.ac.uk/biomodels/MODEL2007210001) and the software tool, findCPcli, that implements the computational method is available at https://github.com/findCP/findCPcli.
© 2021 Bannerman et al.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures








Similar articles
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro.Sci Rep. 2021 Nov 23;11(1):22796. doi: 10.1038/s41598-021-02266-3. Sci Rep. 2021. PMID: 34815498 Free PMC article.
-
Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.Comput Biol Chem. 2021 Dec;95:107599. doi: 10.1016/j.compbiolchem.2021.107599. Epub 2021 Nov 2. Comput Biol Chem. 2021. PMID: 34773807 Free PMC article. Review.
-
Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.Drug Dev Res. 2021 Feb;82(1):12-26. doi: 10.1002/ddr.21720. Epub 2020 Jul 30. Drug Dev Res. 2021. PMID: 33216381 Review.
-
LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network.IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1290-1298. doi: 10.1109/TCBB.2021.3085972. Epub 2021 Aug 6. IEEE/ACM Trans Comput Biol Bioinform. 2021. PMID: 34081583 Free PMC article.
Cited by
-
Mycobacterial metabolic model development for drug target identification.GigaByte. 2023 Apr 30;2023:gigabyte80. doi: 10.46471/gigabyte.80. eCollection 2023. GigaByte. 2023. PMID: 37153490 Free PMC article.
-
Human/SARS-CoV-2 genome-scale metabolic modeling to discover potential antiviral targets for COVID-19.J Taiwan Inst Chem Eng. 2022 Apr;133:104273. doi: 10.1016/j.jtice.2022.104273. Epub 2022 Feb 15. J Taiwan Inst Chem Eng. 2022. PMID: 35186172 Free PMC article.
-
New workflow predicts drug targets against SARS-CoV-2 via metabolic changes in infected cells.PLoS Comput Biol. 2023 Mar 23;19(3):e1010903. doi: 10.1371/journal.pcbi.1010903. eCollection 2023 Mar. PLoS Comput Biol. 2023. PMID: 36952396 Free PMC article.
-
COVID-19: A complex disease with a unique metabolic signature.PLoS Pathog. 2023 Nov 9;19(11):e1011787. doi: 10.1371/journal.ppat.1011787. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 37943960 Free PMC article.
-
Reconstructed Genome-Scale Metabolic Model Characterizes Adaptive Metabolic Flux Changes in Peripheral Blood Mononuclear Cells in Severe COVID-19 Patients.Int J Mol Sci. 2022 Oct 17;23(20):12400. doi: 10.3390/ijms232012400. Int J Mol Sci. 2022. PMID: 36293257 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous